Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
|SU-I-GPD-T-447||Imaging Contrast Enhancement On Nanoparticle Addition: A Monte Carlo Evaluation|
F Albayedh1 , J Chow2*, (1) Ryerson University, Toronto, ON, (2) Princess Margaret Cancer Centre, Toronto, ON
|SU-J400-CAMPUS-F1-2||A Novel Diseased-Liver Mimicking Perfusion Phantom for Evaluating Subharmonic Dynamic Contrast-Enhanced Ultrasound Techniques|
A Ivory1*, A Fagan2 , J Browne3 , (1) University of Dublin, Dublin 8, Ireland, (2) Mayo Clinic, Rochester, MN, (3) Dublin Institute of Technology, Dublin 8, Ireland
|TH-AB-202-3||Contrast-Enhanced Photon Counting CT Using Bayesian Eigentissue Decomposition for Radiotherapy Applications|
M Simard1*, A Lapointe1 , A Lalonde1 , H Bouchard1,2 , (1) Departement de physique, Universite de Montreal, Quebec, Canada, (2) Centre de recherche du Centre hospitalier de l'Universite de Montreal, Quebec, Canada
|TU-E115-GePD-F1-2||Contrast Enhance Digital Mammography Based On Photon-Counting Detector|
M Lee*, D Lee , H Kim , D Kim , H Kim , Yonsei University, Wonju, Gangwon
|TU-K-202-8||The Quantification and Comparison of the Inherent Radiopacity of Glass Microspheres Used in Transarterial Radioembolization|
C Henry1*, G Mawko1,2,3,6, E Tonkopi1,2,3, J Frampton4, R Abraham2,7, D Boyd5,7, S Kehoe5,7, A Syme6 (1) Department of Physics and Atmospheric Science, Dalhousie University, Halifax, Nova Scotia, Canada (2) Department of Diagnostic Imaging, Dalhousie University, Halifax, Nova Scotia, Canada (3) Department of Medical Physics, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada (4) Department of Biomedical Engineering, Dalhousie University, Halifax, Nova Scotia, Canada (5) Department of Applied Oral Sciences, Dalhousie University, Halifax, Nova Scotia, Canada (6) Department of Radiation Oncology, Dalhousie University, Halifax, Nova Scotia, Canada (7) ABK Biomedical Inc., Halifax, Nova Scotia, Canada
|TU-K-207-5||Optimisation of Subharmonic Generation by Native and Altered Populations of the Ultrasound Contrast Agent SonoVue|
A Ivory1*, J Browne2 , A Fagan3 , (1) University of Dublin, Dublin 8, Ireland, (2) Dublin Institute of Technology, Dublin 8, Ireland, (3) Mayo Clinic, Rochester, MN
|TU-K-207-9||Ultrasound Activatable Nanodroplets Targeted to EGFR for Molecular Imaging with High-Frequency Ultrasound|
T Mitcham1,2*, D Nevozhay1 , S Lai1 , K Sokolov1,2,3 , R Bouchard1,2 , (1) University of Texas MD Anderson Cancer Center, Houston, TX, (2) MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, (3) University of Texas, Austin, TX